Literature DB >> 31750177

Study the Effect of Tubotympanic Disease on Bone Conduction Threshold.

Nitish Baisakhiya1, Gurchand Singh1.   

Abstract

Tubo-tympanic disease of middle ear cleft can temporarily detoriate the bone conduction threshold specially in higher frequency in long standing cases. It mainly affects the inertial ossicular component of the bone conduction mechanism. (1) Study the effect of tubotympanic disease on bone conduction threshold (SN loss). (2) Study the duration of the disease on bone conduction threshold. 84 cases of tubotympanic disease were taken for the study. There pre-operative PTA was done and effect of the disease on the bone conduction threshold was noted. Results were analyzed by using analysis of variance. The significance level α was taken 0.05 as at marginally significant, 0.01 significant and 0.001 as highly significant. The bone conduction at all frequencies increased significantly P < 0.05 with duration of ear discharge. The differences in the bone conduction at all frequencies amongst normal ears were significantly lower as compared to the diseased ear. Duration of ear discharge and type of hearing loss reveals that in patients with ear discharge less than 11 years there were 24 (77.41%) subjects with conductive hearing loss, 1 (3.22%) subject with mixed hearing loss. As the duration increased 11-20 years, the cases of conductive hearing loss decreased 13 (56.52%) and cases of mixed hearing loss increased to 3 (13.04%). In patients with ear discharge of > 21 years conductive subjects were 19 (63.33%) and subjects with mixed hearing loss increased to 5 (33.33%) cases. The average hearing loss and the average bone conduction threshold increases as the duration of disease increases. In patients of safe CSOM who have poor BCT, it is the higher frequencies which are more affected. © Association of Otolaryngologists of India 2018.

Entities:  

Keywords:  Bone conduction threshold; CSOM; Higher frequency

Year:  2018        PMID: 31750177      PMCID: PMC6841814          DOI: 10.1007/s12070-018-1424-2

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  13 in total

Review 1.  Recent advances in otitis media. 1. Definitions, terminology, and classification of otitis media.

Authors:  George A Gates; Jerome O Klein; David J Lim; Goro Mogi; Pearay L Ogra; Michael M Pararella; Jack L Paradise; Mirko Tos
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  2002-03

2.  Chronic otitis media as a cause of sensorineural hearing loss.

Authors:  G M English; J L Northern; T J Fria
Journal:  Arch Otolaryngol       Date:  1973-07

3.  Audiologic manifestations in otitis media.

Authors:  I Eliachar
Journal:  Otolaryngol Clin North Am       Date:  1978-10       Impact factor: 3.346

4.  Sensorineural loss in chronic otitis media. Is it clinically significant?

Authors:  B A Levine; C Shelton; K I Berliner; J L Sheehy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-07

5.  Sensorineural hearing loss in otitis media.

Authors:  M M Paparella; T Morizono; C T Le; F Mancini; P Sipilä; Y B Choo; G Lidén; C S Kim
Journal:  Ann Otol Rhinol Laryngol       Date:  1984 Nov-Dec       Impact factor: 1.547

6.  Sensorineural hearing loss in chronic otitis media.

Authors:  F Cusimano; V C Cocita; A D'Amico
Journal:  J Laryngol Otol       Date:  1989-02       Impact factor: 1.469

7.  Cochlear function in chronic otitis media.

Authors:  P S Dumich; S G Harner
Journal:  Laryngoscope       Date:  1983-05       Impact factor: 3.325

8.  Chronic suppurative otitis media and sensorineural hearing loss: Is there a correlation?

Authors:  Kamaljit Kaur; Nishi Sonkhya; A S Bapna
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2003-03

Review 9.  Sensorineural hearing loss in acute and chronic middle ear diseases.

Authors:  M Tos
Journal:  Acta Otolaryngol Suppl       Date:  1989

10.  Factors influencing sensorineural hearing loss in chronic otitis media.

Authors:  E Vartiainen; S Karjalainen
Journal:  Am J Otolaryngol       Date:  1987 Jan-Feb       Impact factor: 1.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.